Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacogenetics and pharmacokinetics of tamoxifen in a Zimbabwean breast cancer cohort

British Journal of Clinical Pharmacology(2023)10.1111/bcp.15827Source: DataRank Database

Pharmacogenetics and pharmacokinetics of tamoxifen in a Zimbabwean breast cancer cohort is a research paper published in British Journal of Clinical Pharmacology (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.84)OA: bronzeTopics (43)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Roslyn Thelingwani ORCID,Zedias Chikwambi ORCID,Anna Mary Nyakabau ORCID,Collen Masimirembwa ORCID,Bianza Tinotenda Mbavha ORCID

Live enrichment

PubMed:37337448 PMC:PMC10529681 OpenAlex:https://openalex.org/W4381309074

European and Developing Countries Clinical Trials Partnership

Grant: TMA2016SF‐1508

Bill and Melinda Gates Foundation

Grant: INV‐036801

National Institutes of Health

Grant: 5P20CA210677

European & Developing Countries Clinical Trials Partnership (EDCTP)

Grant: TMA2016SF-1508

NIAID NIH HHS

Grant: T32 AI150547

NCI NIH HHS

Grant: P20 CA210677

FWCI

1.84

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.15827

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.15827

publisherhttps://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15827

journalhttps://doi.org/10.1111/bcp.15827

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37337448

Fields of Study

Pharmacogenetics and Drug MetabolismEstrogen and related hormone effectsInflammatory mediators and NSAID effectsHumansFemaleBreast NeoplasmsPharmacogeneticsCytochrome P-450 CYP2D6Chromatography, LiquidZimbabweAntineoplastic Agents, HormonalTandem Mass SpectrometryTamoxifenGenotype

MeSH Terms

Breast NeoplasmsChromatography, LiquidFemaleGenotypeHumansPharmacogeneticsTamoxifenZimbabweAntineoplastic Agents, HormonalCytochrome P-450 CYP2D6Tandem Mass Spectrometry

Keywords

CYP2D6TamoxifenPharmacogeneticsBreast cancerGenotypingMedicineGenotypePharmacokineticsPharmacologyOncologyActive metaboliteInternal medicineCancerBiologyGeneticsCytochrome P450MetabolismGene

Sustainable Development Goals

SDG 0: Good health and well-being